MYNERVA AG

Reduce falls and improve mobility in diabetic neuropathy

MYNERVA is revolutionizing the treatment of diabetic neuropathy through a smart wearable sensory prosthesis in the form of a smart sock that allows to reduce falls and improve mobility.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
Deal

30.06.2026

First closing Seed Round Completed

Deal

15.05.2026

Start of longitudinal randomized clinical trial

No Jobs

Videos

MYNERVA

No Awards

MYNERVA AG

Reduce falls and improve mobility in diabetic neuropathy

Headquarter:
zurich

Foundation Date:
June 2025

Technology:

  • Medtech

Sectors:

  • Digital Health
  • Hardware
  • Machine Learning / AI
  • Medtech

Support received

  • Support venture leaders